Definitive Contract IND17PC00071
Award Date
1/20/17
Potential Completion Date
2/19/19
Potential Value
$1M
Funding Federal Agency
Defense Advanced Research Projects Agency
Contracting Federal Agency
Interior Business Center
Awardee
Inflammatix, Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94112, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
25
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business, for the development of a host-response prognostic tool called HOSTDXTM-COVID SEVERITY. The $453,851.00 contract is for research, development, and testing services related to diagnostic solutions for COVID-19 and other viral pandemics. Inflammatix has received over $29 million in federal contracts and grants from the Department of Health and Human Services to...
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Inflammatix, Inc., a self-certified small disadvantaged business. The contract is for the development of the HOSTDX-Sepsis diagnostic test, a rapid point-of-care test that analyzes the host immune response to detect and classify sepsis. The contract has a firm fixed price of $510,000.00 and a completion date of November 30, 2021....
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $27,992,718.00 definitive contract to Inflammatix, Inc., a self-certified small disadvantaged business organization, for the development of "a full stack of host-response solutions to infectious disease testing to address outpatient and inpatient testing for acute infections and sepsis both during and outside of influenza season." This contract, which has a...
This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...
<p>The U.S. Defense Advanced Research Projects Agency (DARPA) awarded a Firm Fixed Price, Definitive Contract to Probiusdx Inc., a small business, for point-of-care monitoring of the host-pathogen interaction during infection. The contract has a ceiling value of $1,746,921.00 and a period of performance ending on November 15, 2021. This contract was awarded under DARPA's SBIR (Small Business Innovation Research) Program Phase II. The place of performance is Duncans Mills, CA.</p>
<p>This is a $149,500.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanomedical Diagnostics, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES." The contract was awarded on October 24, 2016 with a final completion date of July 23, 2017.</p>
This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...
This is a $2,761,705.00 Firm Fixed Price Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics. The contract is for the development of point-of-care monitoring of the host-pathogen interaction during infection. Mbio Diagnostics Inc. is a company that develops diagnostic tests and devices, including rapid point-of-care tests, using its proprietary Lightdeck...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...